Report of Foreign Issuer (6-k)
July 31 2018 - 5:46PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form
6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE
13a-16
OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2018
Commission File Number
001-37965
TiGenix
Romeinse
straat 12
3001 Leuven, Belgium
(Address of principal executive office)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form
20-F
or Form
40-F.
Form
20-F ☒
Form
40-F ☐
Indicate by check mark if the registrant is submitting the Form
6-K
in paper as permitted by Regulation
S-T
Rule 101 (b)(1).
Yes ☐ No ☒
Indicate by check mark if the registrant is submitting the Form
6-K
in paper as permitted by Regulation
S-T
Rule 101 (b)(7).
Yes ☐ No ☒
ITEM 1 INFORMATION CONTAINED IN THIS FORM
6-K
REPORT
Attached as Exhibit 99.1 is a copy of the press release issued by Takeda Pharmaceutical Company Limited and TiGenix on July 31, 2018.
ITEM 2 EXHIBITS
The following exhibit is
filed as a part of this report:
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
TIGENIX
|
|
|
|
Date: July 31, 2018
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Claudia DAugusta
|
|
|
|
|
Name:
|
|
Claudia DAugusta
|
|
|
|
|
|
|
|
|
Title:
|
|
General Manager
|
Trean Insurance (NASDAQ:TIG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Trean Insurance (NASDAQ:TIG)
Historical Stock Chart
From Jul 2023 to Jul 2024